Sanofi (SNY) Intangibles (2016 - 2025)

Sanofi (SNY) has disclosed Intangibles for 11 consecutive years, with $30.6 billion as the latest value for Q4 2025.

  • Quarterly Intangibles rose 26.42% to $30.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.6 billion through Dec 2025, up 26.42% year-over-year, with the annual reading at $29.7 billion for FY2025, 21.14% up from the prior year.
  • Intangibles hit $30.6 billion in Q4 2025 for Sanofi, up from $24.2 billion in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $30.6 billion in Q4 2025 to a low of $22.1 billion in Q4 2022.
  • Historically, Intangibles has averaged $25.5 billion across 5 years, with a median of $24.5 billion in 2021.
  • Biggest five-year swings in Intangibles: decreased 9.84% in 2022 and later rose 26.42% in 2025.
  • Year by year, Intangibles stood at $24.5 billion in 2021, then decreased by 9.84% to $22.1 billion in 2022, then rose by 18.51% to $26.2 billion in 2023, then fell by 7.58% to $24.2 billion in 2024, then grew by 26.42% to $30.6 billion in 2025.
  • Business Quant data shows Intangibles for SNY at $30.6 billion in Q4 2025, $24.2 billion in Q4 2024, and $26.2 billion in Q4 2023.